Table 2.
Expression Profile of IL-4, IL-17 and CD163 in Different Stages of Fibrosis in Liver Sections of Chronic Hepatitis C
| IL4 Expression | IL-17 Expression | CD163 Expression | Total n. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Negative n. (%) |
Low n. (%) | High n. (%) |
Negative n. (%) | High n. (%) |
High n. (%) |
Negative n. (%) |
Low n. (%) |
High n. (%) |
|||
| Hepatic Fibrosis | Mild/Moderate | 10a (33.33) | 9b (30.0) | 11b (36.67) | 5a (16.7) | 10a, b (33.3) | 15b (50.0) | 19a (63.33) | 6a, b (20.0) | 5b (16.67) | 30 |
| Marked/Cirrhosis | 4a (13.33) | 6b (20.0) | 20a, b (66.67) | 0a (0.0) | 5a, b (16.7) | 25b (83.3) | 3a (10.0) | 8a, b (26.67) | 19b (63.33) | 30 | |
| Total | 14 (23.33) | 15 (25.0) | 31 (51.67) | 5 (8.3) | 15 (25.0) | 40 (66.7) | 22 (36.7) | 14 (23.3) | 24 (40.0) | 60 | |